INTRODUCTION
Fast dissolving tablets (FDT) are solid single-unit dosage forms that are placed in the mouth, allowed to disperse/dissolve in the saliva and then swallowed without the need for water. FDT's are not only indicated for people who have swallowing difficulties, but also are ideal for active people. FDT's are those when put on tongue disintegrates instantaneously releasing the drug, which dissolves or disperse in saliva 1 .
Salbutamol sulphate is a short-acting ß2-adrenergic receptor agonist used for the relief of bronchospasm in conditions such as asthma and COPD. (Chronic Obstructive Pulmonary Disease). Salbutamol is well absorbed from the gastrointestinal tract having 50% oral bioavailability due to first pass metabolism. Hence an attempt was made for preparing fast dissolving tablet of salbutamol sulphate and compares along with natural and synthetic superdisintegrants. With an aim of reducing the lag time and providing faster onset of action to relieve immediately acute asthmatic attack. This would be advantageous as conventional solid oral dosage forms are often associated with first pass effect, longer lag time and slower onset of action but require careful handling. Aerosol systems are specific but fail to deliver actual dose of drug with only 10 % of administered dose deposited on the bronchi while rest of the drug is deposited in oropharynx and is swallowed. Also, metered dose system are less potable while dry powder inhalers cause clogging of device and require skilful operation. FDT's would be advantageous, as salbutamol sulphate is water soluble and its preparation into FDT's would render it to dissolve rapidly and thereby result in rapid absorption improved oral bioavailability without any lag time 2 .
Various natural substances have been used in the formulations of FDT's. Mucilage of natural origin is preferred over semi-synthetic and synthetic substances because they are comparatively cheaper, abundantly available, non-irritating and nontoxicin nature. In the present investigation, the preparation and evaluation of fast dissolving tablets by using different concentrations of natural superdisintegrant that is Plantago ovata mucilage is studied. The reasons for selection of Plantago ovata mucilage because it's high swelling index. Mucilage of Plantago ovata has various characteristics like binding, disintegrating and sustaining properties. Hence, in present study, mucilage of Plantago ovata was used to develop FDT's of salbutamol sulphate. The concept of formulating FDT's of salbutamol sulphate increases the water uptake with shortest wetting time and there by decrease the disintegration time of the tablets by simple and cost effective direct compression techniques 3, 4 .
MATERIALS AND METHODS

Materials:
Salbutamol Sulphate was gifted by Glenmark Pharmaceuticals Ltd. Nashik. Plantago ovata seeds were purchased from local market Mumbai. Plantago ovata husk powder was obtained as a gift sample from Gayatri Psyllium husk powder, Unjha Gujarat. Crosscarmellose sodium, Sodium starch glycolate, Microcrystalline cellulose, Mannitol, Colloidal silicon dioxide, Talc, Aspartame and Vanillin used were of analytical grades.
Methods:
Formulation of FDT's by direct compression method: Salbutamol sulphate, directly compressible (microcrystalline cellulose), superdisintegrants (POM/POH/croscarmellose sodium/sodium starch glycolate), colloidal silicon dioxide, mannitol, were sifted through the sieve #44 and admixed for about 15 minutes to make a uniform blend. Talc, aspartame, vanillin were passed through sieve #100 and mixed with the above blend for approximately 5-7 minutes. The blend was evaluated for precompression parameters. The resulting uniform blends were directly compressed using 6mm, round convex faced tooling to make the tablets using 10 station compression machine (Rimek, Mini Press-1, Karnavati Engineering Limited). The tablet press setting was kept constant across all formulations.
STANDARD CALIBRATION CURVE
The solutions of salbutamol sulphate in the range of 60-100 μg/ml and 20-100 μg/ml in phosphate buffer pH 6.8 and distilled water were prepared respectively. Absorbance was measured for each solution at λmax of 276.4 nm and 275nm respectively, using UV-Vis Spectrophotometer (Jasco-V630, Japan).
AUTHENTICATION OF Plantago ovata SEEDS
The seeds of Plantago ovata were authenticated from Botany Department NDMVP's junior college, Nashik. The authentication results proves that the seeds are of Plantago ovata belonging to family Plantaginaceae.
METHODOLOGY
FOR ISOLATION OF MUCILAGE
Seeds of Plantago ovata were soaked in distilled water for 48 hrs. Soaked seeds were boiled for 120 minutes till mucilage get released into the water completely. As soon as mucilage gets released the mucilage was squeezed out and separated from seeds with the help of nylon muslin cloth. The mucilage collected and precipitated using 95% ethanol (1: 2) and washed twice with the same. Collected mucilage was dried in the tray dryer at 50-55°C. Dried mucilage was scraped and powdered using mortar and pestle. This crushed and fine powder was then passed through # 80. The mucilage was then kept in dessicator until its use 5 .
Physicochemical and Phytochemical evaluation of dried powdered mucilage 6, 7, 8 Organoleptic properties
Organoleptic properties such as physical appearance, colour, odour and taste of dried powdered mucilage were determined.
Solubility profile
The solubility of dried powdered mucilage was checked by adding a pinch in the solvent such as water.
Charring
A few milligrams of dried mucilage powder and husk powder were placed in a melting-point apparatus. The temperature was taken and recorded when the material started to char.
pH determination
The pH values of solutions prepared in specified strength were determined using calibrated (pH 4 and pH 7) digital pH meter.
Preliminary phytochemical screening
A preliminary phytochemical screening of dried powdered mucilage was carried out for the detection of various phytoconstituents.
Ash values (WHO GUIDELINES)
Total ash, acid-insoluble ash, water-soluble ash, sulphated ash values were evaluated.
Loss on Drying
Loss on Drying was determined for an appropriate quantity of dried powdered mucilage at 105 o C for 5 hours.
LOD (%) = (Wt of water in sample/Wt of dry sample) x 100
Swelling power
The swelling power of the dried mucilage powder was performed as outlined in Indian Pharmacopoeia.
Viscosity determination
Rheological studies of dried mucilage were carried out using varying concentrations (0.1-0.5 w / v ) prepared in distilled water. The viscosities were measured using a Brookfield viscometer spindle no.62 at 100 rpm at 25 o C.
Microbial count
The microbial count of the dried mucilage powder was performed as outlined in Indian Pharmacopoeia for the presence of bacteria as well as for fungi. Total count of bacteria and fungi was calculated using plate count method.
Particle size determination
The particle size of the dried-powder mucilage and husk powder were determined by the microscopic method.
Hydation capacity (water retention capacity)
1gm of dried-powder mucilage was placed in a centrifuge tube and covered with 10 mL of distilled water. The tube was shaken intermittently over 2 hours and left to stand for 10 minutes at 3000 rpm. With the supernatant decanted and the weight of the powder after water uptake and centrifugation, x was determined.
Hydration capacity= x / y
Where x is the weight of moist powder after centrifugation and y is the weight of dry powder respectively.
Flow properties of dried mucilage powder
The flow properties of dried mucilage powder were characterized.
Drug excipients Compatibility studies Fourier Transform Infra-Red Spectroscopy (FTIR)
The drug and physical mixture of drug and excipients were subjected to IR spectroscopic study using FT-IR spectrophotometer (Bruker Alpha ATR).
Differential Scanning Calorimetry
Thermogram of drug and physical mixture (drug: POM); (ratio1:5) were employed (DSC60 SHIMADZU) for the determination of glass transition temperature (Tg).
Various formulations of Salbutamol sulphate (API) fast dissolving tablets(FDTs) were designed utilizing natural superdisintegrants as mucilage of Plantago ovata (POM), husk of Plantago ovata (POH) and synthetic superdisintegrants as Crosscarmelose sodium(CCS), Sodium starch glycolate (SSG) each varied at different concentrations (2, 4, 6, 8 and 10 %). All of the other ingredients were kept constant. A total of such fifteen formulations prepared were designated with their codes and will be referred with the same in further sections. The assigned formulation codes were as follows: SM1, SM2, SM3, SM4 and SM5 for formulations containing mucilage of Plantago ovata and SH1, SH2, SH3, SH4 and SH5 for formulations containing husk of Plantago ovata as a superdisintegrant with concentrations 2, 4, 6, 8 and 10 % respectively. Similarly, SC1, SC2, SC3, SC4 and SC5 also SS1, SS2, SS3, SS4 and SS5 were the assigned codes for the formulations prepared with crosscarmellose sodium, Sodium starch glycolate as superdisintegrants at the percentage levels provided for PO above.
Evaluation of fast dissolving tablets 9, 10
Weight variation
Twenty tablets were selected randomly from each formulation and weighed individually. The individual weights were compared with the average weight for the weight variation.
Hardness and Friability
Hardness of the tablets was measured using the Monsanto hardness tester. The friability of a sample of twenty tablets was measured using a USP type Roche friabilator. Preweighed tablets were placed in a plastic chambered friabilator attached to a motor revolving at a speed of 25 rpm for 4 min. The friability was calculated.
Drug content uniformity
For the content uniformity test, twenty tablets were weighed and pulverized to a fine powder. A quantity of powder equivalent to 4mg of salbutamol sulphate was taken in 100ml volumetric flask containing distilled water. An aliquot of 2ml sample was withdrawn and diluted to 10ml and analysed by UV spectrophotometer at 275nm against blank. Then the amount of drug present was calculater using standard calibration curve. The mean percent drug content was calculated as an average of three determinations.
In vitro disintegration time
Six tablets were placed individually in each tube of disintegration test apparatus and discs were placed. Distilled water was maintained at a temperature of 37°±2°C and time taken for the entire tablet to disintegrate completely was noted.
Wetting time and water absorption ratio (R)
Twice folded tissue paper was placed in a Petri dish having an internal diameter of 6.5 cm to that added 6 ml of purified water. A tablet was carefully placed on the surface of the tissue paper in the Petri dish. The time required for water to reach the upper surface of the tablet and to completely wet it was noted as the wetting time. Water absorption ratio (R) was then determined according to the following equation:
R=[(Wa-Wb) /Wb] x100
Where; Wb and Wa were tablet weights before and after water absorption, respectively.
In vitro drug release study
In vitro dissolution of the tablets was determined using USP-Type-II dissolution test apparatus rotating at 50 rpm in 900 ml pH6.8 phosphate buffer solution as medium maintained at 37±0.5 ºC.The amount of drug in solution was determined spectrophotometrically at 276.4 nm.
Stability study
The fast dissolving tablets were packed in aluminium foil and stored under the following environmental conditions for a period as prescribed by ICH guidelines for accelerated studies at 40 o C and 75% RH. The tablets were withdrawn at end of 90 days and evaluated for parameters including disintegration time, drug content and dissolution study.
RESULT AND DISCUSSION
Phytochemical, microbial and physicochemical characterization of Plantago ovata mucilage
Organoleptic properties
It is creamish fine powder odourless with mucilaginous taste.
Solubility profile
Mucilage does not dissolve in water, it swells. The presence of mucilage was confirmed using ruthenium red and aqueous potassium hydroxide. Both tests were positive. Pre-compression parameters were within prescribed limits and indicated good free flowing property. Batches which show best results are used for further study.
Here, Friability is less than 1 %, Drug content was found to be in the range of 98 to 101 % which is within acceptable limits. Hardness of the tablets was found to be in the range of 2.5-3.0 kg/cm 2 . From the result it was found that formulations SM5, SH5, SS5, SC5 shown best results. Disintegration time of salbutamol sulphate FDT's using mucilage of Plantago ovata, Plantago ovata husk powder, crosscarmellose sodium and sodium starch glycolate as superdisintegrants are shown in Figure 5 . 
Comparative Dissolution Profiles of all the formulations
The in-vitro dissolution profiles of prepared tablets are shown in Table 7 . The graphical representation of in-vitro dissolution profiles of prepare tablets are shown in Figure 6 SM1  SM2  SM3  SM4  SM5  SH1  SH2  SH3  SH4  SH5  SS1  SS2  SS3  SS4  SS5  SC1  SC2  SC3  SC4 Among all the designed formulations SM5, SH5, SC5, SS5 was found to be promising and displayed better results. The formulations SM5, SH5 10% w/w of mucilage of Plantago ovata and husk powder has shown comparable results in all respects than SC5 and SS5 formulations. Invitro dissolution studies on these formulations revealed that more than 90% drug released within 10 min.
Stability studies
No appreciable change in physical characteristics, the results concluded that fast dissolving tablets of salbutamol sulphate were stable during accelerated stability conditions up to three months. (Data not shown).
CONCLUSION
Finally it is concluded that disintegrating properties of the mucilage and husk powder of Plantago ovata has been studied in comparison with croscarmellose sodium and sodium starch glycolate. The isolated natural disintegrant exhibited faster drug dissolution in comparison to the synthetic superdisintegrants. These formulations improve the bioavailability and effective therapy using Plantago ovata mucilage as natural superdisintegrant. Therefore, in the years to come, there will be continued interest in natural mucilages and their modifications aimed at the development of better materials for drug delivery systems.
